Crunch time for funding of universal access to antiretroviral treatment for people with HIV infection

Int J Clin Pract. 2011 Aug;65(8):824-7. doi: 10.1111/j.1742-1241.2011.02697.x.
No abstract available

MeSH terms

  • Anti-HIV Agents / economics
  • Anti-HIV Agents / supply & distribution*
  • Cost-Benefit Analysis
  • Developing Countries*
  • Financing, Organized*
  • HIV Infections / drug therapy*
  • HIV Infections / economics
  • Health Services Accessibility / economics*
  • Humans

Substances

  • Anti-HIV Agents